Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Partial vs No Neuromuscular Block in CPA Tumor Resection
NCT04148534Completed
- Start
- Nov 2019
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of rocuronium in cerebellopontine angle tumor (2 arms). Primary endpoint: End to start facial nerve MEP amplitude ratio. Started Nov 2019; status: completed.
02
Drugs
rocuronium
03
Conditions
cerebellopontine angle tumor
Beyond the preview
Go deeper on NCT04148534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04148534.